mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.1 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.1 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |